178 related articles for article (PubMed ID: 2249186)
1. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
Gaynon PS; Ettinger LJ; Baum ES; Siegel SE; Krailo MD; Hammond GD
Cancer; 1990 Dec; 66(12):2465-9. PubMed ID: 2249186
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
Hurwitz CA; Strauss LC; Kepner J; Kretschmar C; Harris MB; Friedman H; Kun L; Kadota R
J Pediatr Hematol Oncol; 2001; 23(5):277-81. PubMed ID: 11464982
[TBL] [Abstract][Full Text] [Related]
3. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group.
Warren K; Jakacki R; Widemann B; Aikin A; Libucha M; Packer R; Vezina G; Reaman G; Shaw D; Krailo M; Osborne C; Cehelsky J; Caldwell D; Stanwood J; Steinberg SM; Balis FM
Cancer Chemother Pharmacol; 2006 Sep; 58(3):343-7. PubMed ID: 16408203
[TBL] [Abstract][Full Text] [Related]
5. A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors.
Arndt CA; Krailo MD; Steinherz L; Scheithauer B; Liu-Mares W; Reaman GH
Cancer; 1998 Aug; 83(4):813-6. PubMed ID: 9708950
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
[TBL] [Abstract][Full Text] [Related]
7. Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma.
Levin VA; Edwards MS; Gutin PH; Vestnys P; Fulton D; Seager M; Wilson CB
J Neurosurg; 1984 Dec; 61(6):1063-8. PubMed ID: 6502234
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
Corden BJ; Strauss LC; Killmond T; Carson BS; Wharam MD; Kumar AJ; Piantadosi S; Robb PA; Phillips PC
J Neurooncol; 1991 Aug; 11(1):57-63. PubMed ID: 1919647
[TBL] [Abstract][Full Text] [Related]
9. High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors.
Castello MA; Clerico A; Deb G; Dominici C; Fidani P; Donfrancesco A
Am J Pediatr Hematol Oncol; 1990; 12(3):297-300. PubMed ID: 2173440
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.
Fouladi M; Nicholson HS; Zhou T; Laningham F; Helton KJ; Holmes E; Cohen K; Speights RA; Wright J; Pollack IF;
Cancer; 2007 Dec; 110(11):2535-41. PubMed ID: 17932894
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group.
Ettinger LJ; Gaynon PS; Krailo MD; Ru N; Baum ES; Siegel SE; Hammond GD
Cancer; 1994 Feb; 73(4):1297-301. PubMed ID: 8313334
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin in childhood medulloblastoma/PNET: feasibility of an in vivo sensitivity test in an "up-front" study.
Mastrangelo R; Lasorella A; Riccardi R; Colosimo C; Iavarone A; Tornesello A; Mastrangelo S; Ausili-Cefaro G; Di Rocco C
Med Pediatr Oncol; 1995 Mar; 24(3):188-96. PubMed ID: 7838041
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group.
Bertolone SJ; Baum ES; Krivit W; Hammond GD
J Neurooncol; 1989 May; 7(1):5-11. PubMed ID: 2754456
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of recurrent pediatric posterior fossa tumors.
Edwards MS; Levin VA; Wilson CB
Clin Neurosurg; 1983; 30():209-25. PubMed ID: 6667576
[No Abstract] [Full Text] [Related]
15. Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination.
Slavc I; Schuller E; Czech T; Hainfellner JA; Seidl R; Dieckmann K
J Neurooncol; 1998; 38(2-3):213-8. PubMed ID: 9696374
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.
Leary SES; Packer RJ; Li Y; Billups CA; Smith KS; Jaju A; Heier L; Burger P; Walsh K; Han Y; Embry L; Hadley J; Kumar R; Michalski J; Hwang E; Gajjar A; Pollack IF; Fouladi M; Northcott PA; Olson JM
JAMA Oncol; 2021 Sep; 7(9):1313-1321. PubMed ID: 34292305
[TBL] [Abstract][Full Text] [Related]
17. A phase II evaluation of thiotepa in pediatric central nervous system malignancies.
Heideman RL; Packer RJ; Reaman GH; Allen JC; Lange B; Horowitz ME; Steinberg SM; Gillespie A; Kovnar EH; Balis FM
Cancer; 1993 Jul; 72(1):271-5. PubMed ID: 8508417
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiology and pathology of brain tumors in childhood].
Giordana MT
Minerva Med; 1984 Jun; 75(24):1401-6. PubMed ID: 6330617
[TBL] [Abstract][Full Text] [Related]
19. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.
Friedman HS; Krischer JP; Burger P; Oakes WJ; Hockenberger B; Weiner MD; Falletta JM; Norris D; Ragab AH; Mahoney DH
J Clin Oncol; 1992 Feb; 10(2):249-56. PubMed ID: 1732426
[TBL] [Abstract][Full Text] [Related]
20. [Recent data in pathological anatomy of primary brain tumors].
Tommasi M; Zappatini-Tommasi L; Jouvet-Telinge A
Pediatrie; 1991; 46(1):31-7. PubMed ID: 1851281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
